(Q64349279)
Statements
A Randomized, Double-Blinded, Placebo-Controlled Phase II Study of Adjuvant Everolimus Following the Resection of Metastatic Pancreatic Neuroendocrine Tumors to the Liver (English)
0 references
January 2014
0 references
February 2017
0 references
2
0 references
18 year
0 references